David de Glint extends his role at Medical Delta

The Supervisory Board of Medical Delta has extended the appointment of Drs. David de Glint as executive board member and managing director of the consortium by four years, effective September. De Glint has held this position since 2021. During this period, the 2019–2024 program was successfully completed, and in 2024 the new multi-year program of Medical Delta was launched.

As managing director, De Glint has daily responsibility for the Medical Delta office, a small and agile team that initiates, supports, and expands innovation projects. Together with chair Prof. Dr. Sanne de Vries, De Glint also forms the executive management of the Medical Delta consortium, which is advised by a societal and scientific council.

Medical Delta has undergone a transition from a scientific collaboration focused on medical technology to a transdisciplinary consortium that places practical health questions at the center of its innovation projects and research.